Fort Point Capital Partners LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1589282
San Francisco, CA
Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$410,478
-$52,230 QoQ
Shares Held
3,249
-2.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#1,476
of 2,266 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fort Point Capital Partners LLC holds $5,958,387 across 7 Drug Manufacturers - General names. GILD ranks #6 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
7,549 | $1,899,630 | |
| 2 | MRK |
Merck & Co., Inc.
|
7,670 | $985,595 | |
| 3 | AMGN |
Amgen Inc
|
2,701 | $978,086 | |
| 4 | JNJ |
Johnson & Johnson
|
3,548 | $901,085 | |
| 5 | LLY |
ELI LILLY & Co
|
343 | $411,404 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
3,249 | $410,478 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,458 | $372,109 |
All Filings in GILD
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $410,478 | 3,249 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $462,708 | 3,320 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $393,995 | 3,210 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $356,310 | 3,210 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,259,815 | 11,363 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $376,375 | 3,359 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $480,970 | 5,207 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $447,118 | 5,333 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $355,880 | 5,187 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $392,693 | 5,361 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $432,998 | 5,345 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $415,542 | 5,545 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $426,120 | 5,529 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $451,522 | 5,442 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $454,146 | 5,290 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $320,788 | 5,200 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $320,299 | 5,182 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $782,778 | 13,167 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $373,578 | 5,145 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $358,330 | 5,130 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $239,632 | 3,480 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $224,912 | 3,480 | Shares | Sole | 2021-05-10 | |
| 2020-06-30 | $230,820 | 3,000 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||